BioAmber Aims to Prove That “Life is Better With Bio-Based Succinic Acid”

Destiny A. Lopez  |

BioAmber (BIOA), a biotechnology company, is on a mission to bring green chemistry to the forefront of the environmental sector. Headquartered in Montreal, BioAmber is dedicated to the renewable materials space, where its technology platform, as stated on its official website, converts renewable feedstock into building block materials through a combination of industrial biotechnology and chemical catalysis.

The company boasts an impressive product portfolio, which, among others, includes:

  • Bio-based 1,4 Butanediol
  • Life Cycle Analysis
  • Feedstock Development

The company’s lead product, Succinic acid aims to usher in a number of green possibilities. According to the company’s official website, Succinic acid can be used to make a broad range of products, including:

  • Artificial leathers
  • Food and flavor additives
  • Biodegradable plastics
  • Dyes & pigments
  • Pharmaceutical compounds

The company began 2016 with the announcement of its jointly owned Sarnia production plant received four key certifications from accredited certification bodies, signaling to potential clients, not to mention the market, the company’s dedication to reliability, safety and efficiency.

"Obtaining these certifications within four months of start-up is a remarkable achievement and a testament to the operational excellence practiced by our Sarnia team," said Jean-Francois Huc, CEO of BioAmber. "These certifications demonstrate that BioAmber Sarnia is a reliable and professional supplier of bio-based chemicals. They also position us as an industry leader in the fast growing field of sustainable chemicals production.”

Furthermore, BioAmber released its Q3 2016 financial report in early November, revealing a number of positive developments. Highlights from the report include:

  • Sales of bio-succinic acid totaling $3.7 million, a 45% increase when compared to the previous quarter.
  • Cash on hand totaled $15.9 million, a sizeable increase when compared to its $5.5 million cash on hand as of June 30th, 2016.

"We have continued to validate our production process at a commercial scale with our biotechnology, as measured by fermentation performance, achieving operating targets since inception,” said Huc. “Our purification process has also improved every quarter since we started up Sarnia, while our plant uptime and percentage of on-spec product continue to meet target levels." He added, "We will steadily increase our throughput towards full capacity and focus on further efficiency gains throughout our production process."

Huc, before taking on the position of CEO at BioAmber, has held a number of high-level leadership positions within the biotech sector. Previously, he served as COO of Diversified Natural Products, CEO of TGN Biotech, and was founder and CEO of MedExact.

Have you ever wondered what is your personal impact on the health of the planet? Not only does BioAmber join the number of green companies working to raise awareness of one’s environmental impact; but, the company is also working towards solutions to reduce that impact through its innovations within the biotech space. A space, which, by the way, is estimated to be valued at $414.5 billion next year by Transparency Market Research.

The investment community looks forward to future developments from the company.

Aqua Metals will be presenting at the Roth Conference December 13, 2016 in New York. Click Here for registration information

To learn more about BioAmber, visit

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Last Price Change % Change